{"product_id":"cleveland-clinic-vasculitis-advances-and-controversies-2025","title":"Cleveland Clinic Vasculitis Advances and Controversies 2025","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch3\u003eCleveland Clinic Vasculitis Advances and Controversies 2025\u003c\/h3\u003e\n\u003cstrong\u003e Include: 22 videos + 18 pdfs, size: 10.2 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: rheumatologists, allergists\/immunologists, dermatologists, internal medicine physicians\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis comprehensive course dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. Participants will critically appraise emergent treatment options for small vessel vasculitis and large vessel vasculitis. In-depth evaluations will explore the central nervous system involvement in vasculitis and the current and future landscape of glucocorticoid use in vasculitis management.\u003cbr\u003e\u003cbr\u003eThe course will discuss advancements in imaging techniques for large vessel vasculitis and other diagnostic modalities. Participants will appraise the latest diagnostic approaches for giant cell arteritis (GCA), while evaluating the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA. Additionally, the role of plasma exchange in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis will be thoroughly examined.\u003cbr\u003e\u003cbr\u003eBy the end of this course, participants will be equipped with the knowledge to effectively evaluate and implement cutting-edge treatments and diagnostic strategies in their practice.\u003cbr\u003e\u003ch3\u003eWho Should Attend?\u003c\/h3\u003e\n\u003cbr\u003eThe Symposium is directed towards rheumatologists, allergists\/immunologists, dermatologists, internal medicine physicians, nurse practitioners, nurses, and physician assistants interested in the treatment of vasculitis.\u003cbr\u003e\u003ch3\u003e\u003cstrong\u003eAfter completing this course, participants will be able to:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCritically appraise emergent treatment options in small vessel vasculitis and large vessel vasculitis\u003c\/li\u003e\n\u003cli\u003eEvaluate CNS involvement in vasculitis\u003c\/li\u003e\n\u003cli\u003eEvaluate current and future landscape of glucocorticoid use in vasculitis management\u003c\/li\u003e\n\u003cli\u003eDiscuss imaging advancement in large vessel vasculitis and other diagnostic modalities in vasculitis\u003c\/li\u003e\n\u003cli\u003eAppraise the diagnostic modalities in giant cell arteritis\u003c\/li\u003e\n\u003cli\u003eEvaluate the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA\u003c\/li\u003e\n\u003cli\u003eAppraise the role of plasma exchange in ANCA-associated vasculitis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e1 Emergent treatment in small vessel vasculitis.pdf\u003cbr\u003e1 Emerging treatment in small vessel vasculitis.mp4\u003cbr\u003e2 Emergent treatment in large vessel vasculitis.mp4\u003cbr\u003e2 Emergent treatment in large vessel vasculitis.pdf\u003cbr\u003e3 EGPA – What can I offer to my patients.mp4\u003cbr\u003e3 EGPA – What can I offer to my patients.pdf\u003cbr\u003e4 Question \u0026amp; Answer.mp4\u003cbr\u003e5 Central Nervous System involvement in vasculitis.mp4\u003cbr\u003e5 Central Nervous System involvement in vasculitis.pdf\u003cbr\u003e6 Ask the Masters Challenging cases in vasculitis.mp4\u003cbr\u003e6 Ask the Masters Challenging cases in vasculitis.pdf\u003cbr\u003e7 Glucocorticoid use in small vessel vasculitis.mp4\u003cbr\u003e7 Glucocorticoid use in small vessel vasculitis.pdf\u003cbr\u003e8 Glucocorticoid use in large vessel vasculitis.mp4\u003cbr\u003e8 Glucocorticoid use in large vessel vasculitis.pdf\u003cbr\u003e9 Question \u0026amp; Answer.mp4\u003cbr\u003e10 Large vessel vasculitis imaging.mp4\u003cbr\u003e10 Large vessel vasculitis imaging.pdf\u003cbr\u003e11 Kidney pathology in small vessel vasculitis.mp4\u003cbr\u003e11 Kidney pathology in small vessel vasculitis.pdf\u003cbr\u003e12 Pathology in large vessel vasculitis.mp4\u003cbr\u003e12 Pathology in large vessel vasculitis.pdf\u003cbr\u003e13 Eye exam in giant cell arteritis.mp4\u003cbr\u003e13 Eye exam in giant cell arteritis.pdf\u003cbr\u003e14 Question \u0026amp; Answer.mp4\u003cbr\u003e15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.mp4\u003cbr\u003e15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.pdf\u003cbr\u003e16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.mp4\u003cbr\u003e16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.pdf\u003cbr\u003e17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.mp4\u003cbr\u003e17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.pdf\u003cbr\u003e18 Does plasma exchange have a role in ANCA associated vasculitis Alexandra Villa-Forte, MD.mp4\u003cbr\u003e18 Does plasma exchange have a role in ANCA associated vasculitis Alexandra Villa-Forte, MD.pdf\u003cbr\u003e19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.mp4\u003cbr\u003e19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.pdf\u003cbr\u003e20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.mp4\u003cbr\u003e20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.pdf\u003cbr\u003e21 Question \u0026amp; Answer.mp4\u003cbr\u003eAgenda.pdf\u003cbr\u003eMay 8, 2025.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954496082018,"sku":"MED-AMB04605","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/40PhotoFixerBot_21-56-02_UTC-scaled.jpg?v=1779378042","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-vasculitis-advances-and-controversies-2025","provider":"Meducourse","version":"1.0","type":"link"}